Which OSA Patients Might Respond to Nasal Valves?

Affiliations

Comment

Robert L Owens et al. J Clin Sleep Med. 2011.

. 2011 Feb 15;7(1):23-4.

¹ Division of Sleep Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115, USA. rowens@partners.org

No abstract available

Comment on

Predictors of response to a nasal expiratory resistor device and its potential mechanisms of action for treatment of obstructive sleep apnea.
Patel AV, Hwang D, Masdeu MJ, Chen GM, Rapoport DM, Ayappa I. Patel AV, et al. J Clin Sleep Med. 2011 Feb 15;7(1):13-22. J Clin Sleep Med. 2011. PMID: 21344051 Free PMC article. Clinical Trial.

1. Patel AV, Hwang D, Masdeu MJ, Chen GM, Rapoport DM, Ayappa I. Predictors of response to a nasal expiratory resistor device and its potential mechanisms of action for treatment of obstructive sleep apnea. J Clin Sleep Med. 2011;7:13–22. - PMC - PubMed
1. Berry R, et al. A novel expiratory positive airway pressure (EPAP) device for the treatment of obstructive sleep apnea: a randomized controlled trial. Sleep. In press. - PMC - PubMed
1. Owens R, Wellman A, Malhotra A. The chicken-or-egg debate in OSA pathogenesis. Sleep. 2009;32:1255–6. - PMC - PubMed
1. Gleeson K, Zwillich CW, White DP. The influence of increasing ventilatory effort on arousal from sleep. Am Rev Respir Dis. 1990;142:295–300. - PubMed
1. Owens RL, Malhotra A, Eckert DJ, White DP, Jordan AS. The influence of end-expiratory lung volume on measurements of pharyngeal collapsibility. J Appl Physiol. 2010;108:445–51. - PMC - PubMed